ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
87 hedge funds and large institutions have $141M invested in ChemoCentryx, Inc. in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 6 closing their positions.
112% more call options, than puts
Call options by funds: $165K | Put options by funds: $78K
24% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 25
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
1% more funds holding
Funds holding: 86 → 87 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less capital invested
Capital invested by funds: $177M → $141M (-$36.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.83M |
| 2 |
UC
Unterberg Capital
New York
|
+$686K |
| 3 |
Morgan Stanley
New York
|
+$400K |
| 4 |
SCM
Sio Capital Management
New York
|
+$400K |
| 5 |
Goldman Sachs
New York
|
+$320K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IHM
Iguana Healthcare Management
New York
|
-$1.2M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$880K |
| 3 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
-$589K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$583K |
| 5 |
ADEF
Adams Diversified Equity Fund
Baltimore,
Maryland
|
-$533K |
CCXI Hedge Fund Activity: Q4 2017 in Review
87 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2017, worth a combined $141M — down 20% from $177M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CCXI positions and 6 closed out — a net gain of 1 holder — while 31 added to existing stakes and 25 trimmed.
The largest buyer was Nantahala Capital Management, adding an estimated $1.83M. The largest seller was Iguana Healthcare Management, cutting an estimated $1.2M.
- 87 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q4 2017, up from 86 in Q3 2017.
- Funds reported $141M of ChemoCentryx, Inc. stock for Q4 2017, down 20% quarter-over-quarter.
- 7 funds opened new ChemoCentryx, Inc. positions in Q4 2017 and 6 closed out, a net change of +1 holder.
- The largest ChemoCentryx, Inc. buyer in Q4 2017 was Nantahala Capital Management, an estimated $1.83M added.
- The largest ChemoCentryx, Inc. seller in Q4 2017 was Iguana Healthcare Management, an estimated $1.2M sold.
Based on aggregated 13F filings for Q4 2017.